Introduction to cerebral blood flow diagram

WA-810 Digital Cerebral Blood Flow Detector (D-REG) is a high-tech product independently developed and produced by Tianjin Wanan Kangtai Medical Technology Co., Ltd., a national high-tech enterprise. It has With independent intellectual property rights, it is the only "Digital Impedance Blood Flow Detector" product that can be found on the official website of the State Food and Drug Administration. Many technologies are leading in domestic and foreign medical clinical practice.

WA-810 Digital Cerebral Blood Flow Detector (D-REG) has obtained 2 patents (ZL201120262532.4; ZL201120262609.8), 1 "Software Product Registration Certificate", and 3 patents "Software Copyright Registration Certificate"; and obtained 5 provincial and ministerial level scientific and technological innovation projects.

The instrument uses bioelectrical impedance technology, using the electrical characteristics and changing patterns of the human body and organs to extract hemodynamic information related to human physiology and pathology; it mainly reflects the intracranial arterial system and vertebral-basal The vascular elasticity, tension, pulsatile filling and cerebral vascular resistance of the arterial system are used to observe the pulsatile blood supply intensity and hemodynamic conditions of the head to determine cerebrovascular function and pathophysiological changes.

The instrument reflects 15 test parameters each including left and right cerebrovascular pulsatile blood volume, cerebrovascular elasticity, and cerebrovascular tone, as well as 2 functional tests. Main clinical significance:

1. Early diagnosis and classification of cerebral arteriosclerosis; differential diagnosis of physiological vascular hypoelasticity and pathological cerebral arteriosclerosis.

2. Diagnosis and differential diagnosis of vascular tension, spasm, dilation, traumatic headache, migraine and other headaches.

3. Differential diagnosis of cervical spondylosis and vertebrobasilar artery insufficiency.

4. Data-based chronic disease management is used for screening of high-risk groups for cardiovascular and cerebrovascular diseases, diagnosis and treatment plan design, data-based condition monitoring and prognosis judgment, follow-up of treatment or rehabilitation process and efficacy evaluation, and establishing the basis for doctors and patients. Trust communication relationships.

5. Traditional Chinese medicine physiotherapy and treatment, spinal nerve rehabilitation medicine, real-time monitoring of brain blood flow, prognosis judgment and efficacy evaluation before and after craniocerebral surgery.

6. Hemodynamic monitoring of various mental disorders such as autonomic nervous system disorders, insomnia, depression, schizophrenia, etc.

7. Cerebral hemodynamic monitoring and auxiliary diagnosis in patients with epilepsy.

8. Auxiliary diagnosis of hypertension and diabetic neuropathy, application in the precursor stage of stroke and evaluation of rehabilitation status.

9. Auxiliary diagnosis of hemorrhage or embolism cerebrovascular disease, and judgment of acute craniocerebral injury.

10. Group monitoring and evaluation of the impact of brain fatigue, brain damage, and occupational harmful factors on cerebral circulation.

11. Vascular age assessment and health examination.